270 related articles for article (PubMed ID: 29028432)
1. Coadministration of Recombinant Adenovirus Expressing GM-CSF with Inactivated H5N1 Avian Influenza Vaccine Increased the Immune Responses and Protective Efficacy Against a Wild Bird Source of H5N1 Challenge.
Wang X; Wang X; Jia Y; Wang C; Tang Q; Han Q; Xiao S; Yang Z
J Interferon Cytokine Res; 2017 Oct; 37(10):467-473. PubMed ID: 29028432
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-expressed recombinant granulocyte monocyte colony-stimulating factor (GM-CSF) enhances protective immunity induced by inactivated Newcastle Disease Virus (NDV) vaccine.
Wang X; Wang X; Jia Y; Wang C; Han Q; Lu ZH; Yang Z
Antiviral Res; 2017 Aug; 144():322-329. PubMed ID: 28698014
[TBL] [Abstract][Full Text] [Related]
3. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
[TBL] [Abstract][Full Text] [Related]
4. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
[TBL] [Abstract][Full Text] [Related]
5. Avian influenza in ovo vaccination with replication defective recombinant adenovirus in chickens: vaccine potency, antibody persistence, and maternal antibody transfer.
Mesonero A; Suarez DL; van Santen E; Tang DC; Toro H
Avian Dis; 2011 Jun; 55(2):285-92. PubMed ID: 21793447
[TBL] [Abstract][Full Text] [Related]
6. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
[TBL] [Abstract][Full Text] [Related]
7. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
[TBL] [Abstract][Full Text] [Related]
8. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
9. Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus.
Pan Z; Zhang X; Geng S; Fang Q; You M; Zhang L; Jiao X; Liu X
Clin Vaccine Immunol; 2010 Apr; 17(4):518-23. PubMed ID: 20107004
[TBL] [Abstract][Full Text] [Related]
10. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
11. Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken.
Xiao J; Zhang L; Wang Z; Xiang W; Lu P; Zhao Y; Han M; Ma A; Qi P; Wang M; Gao GF; Liu WJ
Sci China Life Sci; 2017 Dec; 60(12):1340-1347. PubMed ID: 29230639
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
[TBL] [Abstract][Full Text] [Related]
13. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
[TBL] [Abstract][Full Text] [Related]
14. Positive regulation of humoral and innate immune responses induced by inactivated Avian Influenza Virus vaccine in broiler chickens.
Abdallah F; Hassanin O
Vet Res Commun; 2015 Dec; 39(4):211-6. PubMed ID: 26329833
[TBL] [Abstract][Full Text] [Related]
15. Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.
Bertran K; Thomas C; Guo X; Bublot M; Pritchard N; Regan JT; Cox KM; Gasdaska JR; Dickey LF; Kapczynski DR; Swayne DE
Vaccine; 2015 Jul; 33(30):3456-62. PubMed ID: 26067184
[TBL] [Abstract][Full Text] [Related]
16. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
[TBL] [Abstract][Full Text] [Related]
19. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
[TBL] [Abstract][Full Text] [Related]
20. Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.
Niqueux E; Guionie O; Amelot M; Jestin V
Vaccine; 2013 Aug; 31(38):4121-8. PubMed ID: 23845804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
